Company type | Public |
---|---|
Industry | Biopharmaceuticals |
Founded | September 1987 |
Founder | Brook Byers[1] |
Headquarters | San Diego, California, U.S. |
Key people | John Higgins (CEO) |
Revenue | US$141 million (2017)[2] |
Number of employees | 155 (2020)[3] |
Website | ligand |
Ligand Pharmaceuticals Incorporated is a biopharmaceutical company located in San Diego, California.[4] Founded in 1987 as Progenix Inc., the company went public in 1992. Initially focused on developing its own drugs, a period of turbulence in the early 2000s culminated in its CEO being ejected by the shareholders and provoked a change in focus to the acquisition of existing drugs and forming partnerships to develop them further.[citation needed]
The company has been the subject of multiple regulatory investigations,[5] negative shorts-seller reports[6] and class action lawsuits amid allegations of securities fraud.[7][8][9][10]
In 2018 its CEO was listed among the top five highest paid CEOs in San Diego.[11]
Xconomy
was invoked but never defined (see the help page).:0
was invoked but never defined (see the help page).:1
was invoked but never defined (see the help page).:2
was invoked but never defined (see the help page).:4
was invoked but never defined (see the help page).